Correlation Between Vascular Biogenics and Amgen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vascular Biogenics and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vascular Biogenics and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vascular Biogenics and Amgen Inc, you can compare the effects of market volatilities on Vascular Biogenics and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vascular Biogenics with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vascular Biogenics and Amgen.

Diversification Opportunities for Vascular Biogenics and Amgen

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vascular and Amgen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vascular Biogenics and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Vascular Biogenics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vascular Biogenics are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Vascular Biogenics i.e., Vascular Biogenics and Amgen go up and down completely randomly.

Pair Corralation between Vascular Biogenics and Amgen

Given the investment horizon of 90 days Vascular Biogenics is expected to under-perform the Amgen. In addition to that, Vascular Biogenics is 5.7 times more volatile than Amgen Inc. It trades about -0.03 of its total potential returns per unit of risk. Amgen Inc is currently generating about 0.04 per unit of volatility. If you would invest  21,973  in Amgen Inc on January 25, 2024 and sell it today you would earn a total of  5,500  from holding Amgen Inc or generate 25.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy73.74%
ValuesDaily Returns

Vascular Biogenics  vs.  Amgen Inc

 Performance 
       Timeline  
Vascular Biogenics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vascular Biogenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Vascular Biogenics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Vascular Biogenics and Amgen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vascular Biogenics and Amgen

The main advantage of trading using opposite Vascular Biogenics and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vascular Biogenics position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.
The idea behind Vascular Biogenics and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators